A GENERAL OVERVIEW OF AMIODARONE TOXICITY - ITS PREVENTION, DETECTION, AND MANAGEMENT

被引：90

作者：

VROBEL, TR

MILLER, PE

MOSTOW, ND

RAKITA, L

机构：

[1] CLEVELAND METROPOLITAN GEN HOSP,DEPT MED,DIV CARDIOL,3395 SCRANTON RD,CLEVELAND,OH 44109

[2] CASE WESTERN RESERVE UNIV,SCH MED,CLEVELAND,OH 44106

来源：

PROGRESS IN CARDIOVASCULAR DISEASES | 1989年 / 31卷 / 06期

关键词：

D O I：

10.1016/0033-0620(89)90016-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：393 / 426

页数：34

共 268 条

[1] AMIODARONE AND ITS DESETHYL METABOLITE - TISSUE DISTRIBUTION AND MORPHOLOGIC CHANGES DURING LONG-TERM THERAPY [J].

ADAMS, PC ;

HOLT, DW ;

STOREY, GCA ;

MORLEY, AR ;

CALLAGHAN, J ;

CAMPBELL, RWF .

CIRCULATION, 1985, 72 (05) :1064-1075

[2] AMIODARONE-INDUCED HYPERSENSITIVITY PNEUMONITIS - EVIDENCE OF AN IMMUNOLOGICAL CELL-MEDIATED MECHANISM [J].

AKOUN, GM ;

GAUTHIERRAHMAN, S ;

MILLERON, BJ ;

PERROT, JY ;

MAYAUD, CM .

CHEST, 1984, 85 (01) :133-135

[3] THYROID-DYSFUNCTION DURING CHRONIC AMIODARONE THERAPY [J].

ALBERT, SG ;

ALVES, LE ;

ROSE, EP .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (01) :175-184

[4]

ALINOVI A, 1984, J AM ACAD DERMATOL, V12, P536

[5] MECHANISM OF WARFARIN POTENTIATION BY AMIODARONE - DOSE-DEPENDENT AND CONCENTRATION-DEPENDENT INHIBITION OF WARFARIN ELIMINATION [J].

ALMOG, S ;

SHAFRAN, N ;

HALKIN, H ;

WEISS, P ;

FARFEL, Z ;

MARTINOWITZ, U ;

BANK, H .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (03) :257-261

[6] INTRAVENOUS AMIODARONE IN THE TREATMENT OF REFRACTORY ARRHYTHMIAS [J].

ALVES, LE ;

ROSE, EP ;

CAHILL, TB .

CRITICAL CARE MEDICINE, 1985, 13 (09) :750-752

[7]

ALVES LE, 1982, JAMA-J AM MED ASSOC, V248, P1448

[8] CLINICAL AND CHEMICAL ASSESSMENT OF THYROID-FUNCTION DURING THERAPY WITH AMIODARONE [J].

AMICO, JA ;

RICHARDSON, V ;

ALPERT, B ;

KLEIN, I .

ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (03) :487-490

[9]

ANTONELLI D, 1986, NEW ENGL J MED, V315, P1553

[10]

ATIGER RD, 1972, NEW ENGL J MED, V287, P562

← 1 2 3 4 5 6 7 8 9 10 →